Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

THE CAMPAIGN FOR SUSTAINABLE RX PRICING

Filed by MEHLMAN CONSULTING, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 20, 2026
Income
$90,000.00
Expenses
Not reported
Filing UUID
7283a169-a2bb-4340-acbc-dcf272a16fc0
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Prescription drug pricing issues. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S. 229 - The Drug-price Transparency for Consumers (DTC) Act of 2025..

Literal federal measure citations: H.R. 3789, S. 229

PHA · Pharmacy

Prescription drug pricing issues. H.R. 1843/S. 1032 - Increasing Transparency in Generic Drug Applications Act. S. 1954/H.R. 5526 - Biosimilar Red Tape Elimination Act; S. 1095 - Stop Stalling Act S. 2630 - Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act H.R.1262 - Mikaela Naylon Give Kids a Chance Act. S. 3014 - Ensuring Timely Access to Generics Act of 2025 S. 1414 - Expedited Access to Biosimilars Act

Literal federal measure citations: H.R. 1843, S. 1032, S. 1954, H.R. 5526, S. 1095, S. 2630, H.R.1262, S. 3014, S. 1414

CPT · Copyright/Patent/Trademark

Patent abuse issues. S.1040 - Drug Competition Enhancement Act. S.1041 - Affordable Prescriptions for Patients Act. S.1096 - Preserve Access to Affordable Generics and Biosimilars Act. S. 1097/H.R. 4570 - Interagency Patent Coordination and Improvement Act of 2025. S. 43/H.R. 6485 - Skinny Labels, Big Savings Act. H.R. 3269/S. 2276 - Eliminating Thickets to Increase Competition (ETHIC) Act. H.R. 3160/S. 1533 - The Prevail Act. H.R. 3152/S. 1546 - Patient Eligibility Restoration Act.

Literal federal measure citations: S.1040, S.1041, S.1096, S. 1097, H.R. 4570, S. 43, H.R. 6485, H.R. 3269, S. 2276, H.R. 3160, S. 1533, H.R. 3152, S. 1546

TAX · Taxation/Internal Revenue Code

S. 1785/H.R. 3010 - The No Handouts for Drug Advertisements Act.

Literal federal measure citations: S. 1785, H.R. 3010

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.